Chiaki Nakaseko Selected Research

POEMS Syndrome (Syndrome, POEMS)

1/2021	Successful second autologous stem-cell transplantation for patients with relapsed and refractory POEMS syndrome.
1/2019	[POEMS syndrome: advances in molecular pathophysiology and treatment].
1/2019	Genetic and transcriptional landscape of plasma cells in POEMS syndrome.
10/2018	Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome.
1/2018	Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan.
1/2018	Clonal immunoglobulin λ light-chain gene rearrangements detected by next generation sequencing in POEMS syndrome.
2/2017	Safety and Efficacy of Granulocyte Colony-Stimulating Factor Monotherapy for Peripheral Blood Stem Cell Collection in POEMS Syndrome.
4/2016	Acutely deteriorated extravascular volume overload during peripheral blood stem cell mobilization in POEMS syndrome: A case series with cytokine analysis.
2/2014	Autologous stem cell transplantation for POEMS syndrome.
12/2013	Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chiaki Nakaseko Research Topics

Disease

16	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2019 - 10/2008
15	POEMS Syndrome (Syndrome, POEMS) 01/2021 - 08/2008
14	Neoplasms (Cancer) 01/2021 - 08/2008
14	Multiple Myeloma 01/2021 - 11/2007
12	Leukemia 07/2015 - 12/2003
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 01/2007
8	Lymphoma (Lymphomas) 07/2022 - 01/2012
6	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 08/2004
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021 - 03/2013
5	Paraproteinemias (Monoclonal Gammopathy) 01/2018 - 08/2008
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2014 - 09/2002
4	Infections 01/2018 - 01/2012
4	Philadelphia Chromosome 09/2017 - 05/2011
3	Atherosclerosis 07/2022 - 01/2003
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 12/2021 - 01/2015
3	Hemorrhage 01/2021 - 01/2015
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 03/2013
3	Disease Progression 08/2019 - 01/2018
3	Pericardial Effusion 01/2016 - 05/2011
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2019 - 01/2015
2	Iron Overload 07/2019 - 01/2015
2	Residual Neoplasm 01/2019 - 07/2015
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2019 - 01/2018
2	Monoclonal Gammopathy of Undetermined Significance 01/2019 - 01/2019
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2018 - 10/2013
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2018 - 12/2017
2	Acute Promyelocytic Leukemia 01/2016 - 10/2013
2	Cytokine Release Syndrome 01/2016 - 03/2010
2	Epstein-Barr Virus Infections 01/2016 - 08/2004
2	Hodgkin Disease (Hodgkin's Disease) 01/2016 - 03/2010
2	Pathologic Complete Response 01/2015 - 02/2011
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2014 - 10/2013
2	Ascites 01/2014 - 01/2013
2	Hepatitis B 01/2012 - 05/2007
2	Bronchiolitis Obliterans Syndrome 04/2007 - 12/2003
1	COVID-19 12/2021
1	Respiratory Insufficiency (Respiratory Failure) 12/2021
1	Bacterial Infections (Bacterial Infection) 10/2021
1	Sepsis (Septicemia) 10/2021
1	Immunoglobulin Light-chain Amyloidosis 01/2021
1	Eosinophilia 12/2019
1	BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative) 12/2019

Drug/Important Bio-Agent (IBA)

11	Imatinib Mesylate (Gleevec)FDA Link 12/2019 - 07/2010
10	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2011
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 08/2008
8	nilotinib FDA Link 11/2018 - 05/2011
7	Biomarkers (Surrogate Marker)IBA 10/2021 - 08/2012
6	Tyrosine Kinase InhibitorsIBA 04/2019 - 04/2012
5	Cytarabine (Cytosar-U)FDA LinkGeneric 07/2015 - 02/2011
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2022 - 09/2002
4	Rituximab (Mabthera)FDA Link 07/2022 - 01/2012
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 11/2007
4	RNA (Ribonucleic Acid)IBA 01/2019 - 03/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2012
4	CytokinesIBA 04/2016 - 06/2011
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2016 - 11/2012
4	Bortezomib (Velcade)FDA Link 01/2015 - 01/2012
3	Methotrexate (Mexate)FDA LinkGeneric 12/2021 - 01/2013
3	Proteasome InhibitorsIBA 01/2021 - 02/2014
3	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 08/2008
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2017 - 01/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2022 - 03/2010
2	Prednisolone (Predate)FDA LinkGeneric 07/2022 - 01/2016
2	Lenalidomide (CC 5013)FDA Link 01/2020 - 01/2015
2	Immunomodulating AgentsIBA 08/2019 - 07/2019
2	Immunoglobulin M (IgM)IBA 01/2019 - 01/2018
2	Dasatinib (BMS 354825)FDA Link 01/2018 - 04/2014
2	bosutinibIBA 09/2017 - 01/2015
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2017 - 12/2009
2	Monoclonal AntibodiesIBA 01/2017 - 12/2013
2	Messenger RNA (mRNA)IBA 03/2015 - 04/2013
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2015 - 01/2014
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2014 - 01/2012
2	Urokinase Plasminogen Activator ReceptorsIBA 03/2014 - 04/2013
2	Interleukin-2 Receptors (IL 2 Receptor)IBA 03/2014 - 01/2014
2	Phosphotransferases (Kinase)IBA 06/2011 - 08/2008
1	Vincristine (Oncovin)FDA LinkGeneric 07/2022
1	von Willebrand FactorIBA 07/2022
1	antithrombin III-protease complexIBA 12/2021
1	plasmin-plasmin inhibitor complexIBA 12/2021
1	fibrin fragment D (D-dimer)IBA 12/2021
1	Fibrinogen (Factor I)FDA Link 12/2021
1	Busulfan (Busulfex)FDA Link 12/2021
1	EnzymesIBA 10/2021
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	PTC596IBA 01/2021
1	elotuzumabIBA 01/2020
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 12/2019
1	Co-Repressor ProteinsIBA 10/2019

Therapy/Procedure

21	Therapeutics 07/2022 - 08/2004
16	Stem Cell Transplantation 01/2021 - 12/2003
12	Drug Therapy (Chemotherapy) 07/2022 - 03/2010
10	Hematopoietic Stem Cell Transplantation 01/2020 - 05/2007
8	Transplantation 01/2021 - 01/2003
4	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021 - 09/2002
2	Aftercare (After-Treatment) 01/2019 - 01/2015
2	Radiotherapy 10/2018 - 12/2014
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2016 - 01/2007
2	Remission Induction 02/2012 - 02/2011